Joint (NASDAQ:JYNT) Price Target Cut to $15.00 by Analysts at Roth Mkm

Joint (NASDAQ:JYNT) had its price objective dropped by analysts at Roth Mkm from $16.00 to $15.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Roth Mkm’s price objective suggests a potential upside of 32.04% from the company’s previous close.

Separately, StockNews.com downgraded Joint from a “buy” rating to a “hold” rating in a report on Thursday.

Joint Stock Performance

Shares of JYNT traded down $0.52 during trading hours on Friday, hitting $11.36. The stock had a trading volume of 35,523 shares, compared to its average volume of 67,960. The firm has a market capitalization of $170.40 million, a price-to-earnings ratio of -11.59 and a beta of 1.57. The firm has a 50-day moving average price of $11.25 and a 200 day moving average price of $12.97. Joint has a fifty-two week low of $7.31 and a fifty-two week high of $17.82.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The company had revenue of $30.26 million for the quarter, compared to analyst estimates of $29.65 million. Joint had a negative net margin of 12.00% and a positive return on equity of 2.17%. As a group, analysts predict that Joint will post 0.13 EPS for the current fiscal year.

Institutional Investors Weigh In On Joint

Large investors have recently made changes to their positions in the business. Los Angeles Capital Management LLC acquired a new stake in shares of Joint in the 2nd quarter worth about $1,115,000. Clayton Partners LLC lifted its position in shares of Joint by 38.1% during the 2nd quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock valued at $2,622,000 after acquiring an additional 51,500 shares during the last quarter. Ancora Advisors LLC increased its stake in Joint by 105.0% in the 1st quarter. Ancora Advisors LLC now owns 99,212 shares of the company’s stock worth $1,296,000 after purchasing an additional 50,815 shares in the last quarter. First Foundation Advisors lifted its position in shares of Joint by 18.8% in the 1st quarter. First Foundation Advisors now owns 209,301 shares of the company’s stock valued at $2,733,000 after acquiring an additional 33,104 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Joint by 5.5% in the second quarter. Renaissance Technologies LLC now owns 394,478 shares of the company’s stock worth $5,546,000 after buying an additional 20,400 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.